County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019

Corry, Brian; Underwood, Natasha; Cremer, Laura; Rooks-Peck, Cherie; Jones, Christopher M.

doi:10.1016/j.drugalcdep.2022.109495

Cited by 6 publications

(6 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These gaps are notably pronounced in various geographic locations, including both state and county levels, with rural areas facing particular challenges [20]. To address these disparities, numerous studies have explored MOUD availability [21][22][23], their effect on overdose rates [24], and the correlation with community-level socio-demographic factors [25].…”

Section: Of 14mentioning

confidence: 99%

Exploring Opioid Prescription Patterns and Overdose Rates in South Carolina (2017-2021): Insights into Rising Deaths High-Risk Areas

Sahebi-Fakhrabad,

Sadeghi,

Kemahlioglu-Ziya

et al. 2024

Preprint

View full text Add to dashboard Cite

With opioid overdose rates on the rise, we aim to develop a county-level risk stratification, specifically focusing on access to Medications for Opioid Use Disorder (MOUD) and high overdose rates. We examined over 15 million records from the South Carolina Prescription Tracking System (SCRIPTS) across 46 counties. Additionally, we incorporated data from opioid treatment programs, healthcare professionals prescribing naltrexone, clinicians with buprenorphine waivers, and county-level overdose fatality statistics. To assess the risk of opioid misuse, we classified counties into high-risk and low-risk categories based on prescription rates, overdose fatalities, and treatment service availability. Utilizing statistical methods, we compared prescription patterns and outcomes between these groups. Our study shows that between 2017 and 2021, opioid prescriptions decreased from 64,223 to 41,214 per 100,000 residents, while fentanyl-related overdose deaths increased by 312%. High-risk counties have significantly higher rates of fentanyl prescriptions and rely more on out-of-state doctors. They also exhibit higher instances of doctor shopping and had fewer medical doctors per capita, with limited access to MOUD. To effectively combat the opioid crisis, we advocate for improved local healthcare infrastructure, broader treatment access, stricter management of out-of-state prescriptions, and vigilant tracking of prescription patterns. Tailored local strategies are essential for mitigating the opioid epidemic in these communities.

show abstract

Section: Of 14mentioning

confidence: 99%

Exploring Opioid Prescription Patterns and Overdose Rates in South Carolina (2017-2021): Insights into Rising Deaths High-Risk Areas

Sahebi-Fakhrabad,

Sadeghi,

Kemahlioglu-Ziya

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…These gaps are notably pronounced in various geographic locations, including both state and county levels, with rural areas facing particular challenges [20]. To address these disparities, numerous studies explored MOUD availability [21][22][23], their effects on overdose rates [24], and the correlation with community-level socio-demographic factors [25].…”

Section: Introductionmentioning

confidence: 99%

Exploring Opioid Prescription Patterns and Overdose Rates in South Carolina (2017–2021): Insights into Rising Deaths in High-Risk Areas

Sahebi-Fakhrabad,

Sadeghi,

Kemahlioglu-Ziya

et al. 2024

Healthcare

View full text Add to dashboard Cite

With opioid overdose rates on the rise, we aimed to develop a county-level risk stratification that specifically focused on access to medications for opioid use disorder (MOUDs) and high overdose rates. We examined over 15 million records from the South Carolina Prescription Tracking System (SCRIPTS) across 46 counties. Additionally, we incorporated data from opioid treatment programs, healthcare professionals prescribing naltrexone, clinicians with buprenorphine waivers, and county-level overdose fatality statistics. To assess the risk of opioid misuse, we classified counties into high-risk and low-risk categories based on their prescription rates, overdose fatalities, and treatment service availability. Statistical methods employed included the two-sample t-test and linear regression. The t-test assessed the differences in per capita prescription rates between high-risk and low-risk counties. Linear regression was used to analyze the trends over time. Our study showed that between 2017 and 2021, opioid prescriptions decreased from 64,223 to 41,214 per 100,000 residents, while fentanyl-related overdose deaths increased by 312%. High-risk counties had significantly higher rates of fentanyl prescriptions and relied more on out-of-state doctors. They also exhibited higher instances of doctor shopping and had fewer medical doctors per capita, with limited access to MOUDs. To effectively combat the opioid crisis, we advocate for improved local healthcare infrastructure, broader treatment access, stricter management of out-of-state prescriptions, and vigilant tracking of prescription patterns. Tailored local strategies are essential for mitigating the opioid epidemic in these communities.

show abstract

“…More than a quarter of PWID responding to a recent national survey reported trying but being unable to access MOUD [ 22 ]. Factors that contribute to limited MOUD use are similar to PrEP and include stigma about MOUD [ 23 , 24 ], high out-of-pocket costs—particularly for uninsured patients [ 23 , 25 , 26 ], limited awareness of treatment locations [ 26 ], lack of providers [ 25 , 27 , 28 ], and prior negative healthcare experiences [ 23 , 26 ].…”

Section: Introductionmentioning

confidence: 99%

Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation

et al. 2022

View full text Add to dashboard Cite

Background People who inject drugs (PWID) are at risk for HIV and opioid overdose. We piloted PARTNER UP, a telemedicine-based program to provide PWID with access to both oral pre-exposure prophylaxis (PrEP) for HIV prevention and medication for opioid use disorder (MOUD) through two syringe services programs (SSPs) in North Carolina. We conducted a qualitative evaluation to assess the acceptability and feasibility of PARTNER UP from the participant perspective. Methods PARTNER UP participants met with a provider for an initial in-person visit at the SSP, followed by weekly telemedicine visits in month 1 and then monthly telemedicine visits until program end at month 6. Using a qualitative descriptive study design, we conducted in-depth interviews with a subsample of PARTNER UP participants at 1 month and 4 months. Informed by the technology acceptance model, we assessed participant perceptions of the usefulness and ease of use of PARTNER UP, as well as their intent to continue to use the program’s components. We audio-recorded all interviews with participants’ permission and used applied thematic analysis to analyze the verbatim transcripts. Results We interviewed 11 of 17 people who participated in PARTNER UP—10 in the month 1 interview and 8 in the month 4 interview. Nearly all participants were motivated to join for consistent and easy access to buprenorphine/naloxone (i.e., MOUD); only a few joined to access PrEP. Most were comfortable accessing healthcare at the SSP because of their relationship with and trust toward SSP staff, and accessing services at the SSP was preferred compared with other healthcare centers. Some participants described that telemedicine allowed them to be honest and share more information because the visits were not in-person and they chose the location, although the initial in-person meeting was helpful to build provider trust and rapport. Most participants found the visit schedule to be feasible, although half described needing to reschedule at least once. Nearly all participants who were interviewed intended to continue with MOUD after the program ended, whereas none were interested in continuing with PrEP. Conclusions Participant narratives suggest that the PARTNER UP telemedicine program was acceptable and feasible. Future studies should continue to explore the benefits of embedding both PrEP and MOUD into SSPs with larger numbers of participants. Trial registration Clinicaltrials.gov Identifier: NCT04521920.

show abstract

County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019

Cited by 6 publications

References 52 publications

Exploring Opioid Prescription Patterns and Overdose Rates in South Carolina (2017-2021): Insights into Rising Deaths High-Risk Areas

Exploring Opioid Prescription Patterns and Overdose Rates in South Carolina (2017-2021): Insights into Rising Deaths High-Risk Areas

Exploring Opioid Prescription Patterns and Overdose Rates in South Carolina (2017–2021): Insights into Rising Deaths in High-Risk Areas

Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation

Contact Info

Product

Resources

About